DDOST and chronic myelogenous leukemia, BCR-ABL1 positive: AGER1 expression also showed a significant increase in CML (2.10, 95% CI: 1.30 - 2.90, p = 0.028) compared to OC (1.14, 95% CI: 0.97 - 1.25), although the extent of change was less pronounced than that of RAGE (Figure 3B).